DIAGNOSTIC PREDICTABILITY OF BLOOD TUMOR MARKERS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH LIVER CIRRHOSIS UNDERGOING LIVER TRANSPLANTATION

被引：0
|
作者：
Park, Yo-Han [1 ]
Hwang, Shin [2 ]
机构：
[1] Inje Univ, Busan Paik Hosp, Coll Med, Busan, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
BOS420
引用
收藏
页码：286 / 286
页数：1
相关论文
共 50 条
  • [41] Pulmonary nodules at risk in patients undergoing liver transplantation for hepatocellular carcinoma
    Sotiropoulos, Georgios C.
    Kuehl, Hilmar
    Sgourakis, George
    Molmenti, Ernesto P.
    Beckebaum, Susanne
    Cicinnati, Vito R.
    Baba, Hideo A.
    Schmitz, Klaus J.
    Broelsch, Christoph E.
    Lang, Hauke
    TRANSPLANT INTERNATIONAL, 2008, 21 (09) : 850 - 856
  • [42] Outcome of cirrhotic patients with incidental hepatocellular carcinoma undergoing liver transplantation
    Charco, R
    Hidalgo, E
    Lázaro, JL
    Vargas, V
    Castells, L
    Murio, E
    Bilbao, I
    Margarit, C
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 299 - +
  • [43] Sarcopenia and AFP Level in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation
    Safer, Vildan Binay
    Eyigor, Sibel
    JOURNAL OF SURGICAL RESEARCH, 2019, 243 : 574 - 575
  • [44] Hepatocellular carcinoma in patients undergoing living-donor liver transplantation
    Maetani, Yoji S.
    Ueda, Mikiko
    Haga, Hironori
    Isoda, Hiroyoshi
    Takada, Yasutsugu
    Arizono, Shigeki
    Hirokawa, Yuusuke
    Shimada, Kootaro
    Shibata, Toshiya
    Kaori, Togashi
    INTERVIROLOGY, 2008, 51 : 46 - 51
  • [45] mTOR inhibition for patients with hepatocellular carcinoma undergoing liver transplantation: Is there a rationale?
    Sieghart, W.
    Fuereder, T.
    Schmid, K.
    Cejka, D.
    Wrba, F.
    Wang, X.
    Gruber, D.
    Rasoul-Rockenschaub, S.
    Peck-Radosavljevic, M.
    Wacheck, V.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S109 - S109
  • [46] Predicting Outcomes of Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma Reply
    Sposito, Carlo
    Cucchetti, Alessandro
    Mazzaferro, Vincenzo
    GASTROENTEROLOGY, 2018, 154 (08) : 2276 - 2277
  • [47] LIVER TRANSPLANTATION IN PATIENTS WITH LIVER CIRRHOSIS, HEPATOCELLULAR CARCINOMA (HCC) AND SYNCHRONOUS COLON CANCER: CAN THEY TREAT WITH AN ORTHOTOPIC LIVER TRANSPLANTATION?
    Antoniou, Efstathios
    Damaskos, Christos
    Margonis, Antonios-Georgios
    Paraskeva, Panorea
    Tsinari, Kalliopi
    Lampadariou, Aikaterina
    Tsavaris, Nikolaos
    Kouraklis, Gregory
    TRANSPLANT INTERNATIONAL, 2017, 30 : 408 - 408
  • [48] LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: THE ROLE OF TUMOR MARKERS IN EXPANDED SELECTION CRITERIA
    Takada, Yasutsugu
    Uemoto, Shinji
    LIVER TRANSPLANTATION, 2009, 15 (07) : S82 - S82
  • [49] HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH LIVER CIRRHOSIS
    Resuli, B.
    Babameto, A.
    Basho, J.
    Shehu, K.
    Akshia, I.
    ANNALS OF ONCOLOGY, 2010, 21 : 113 - 113
  • [50] Management of liver cirrhosis in patients with hepatocellular carcinoma
    Ismail, Bahaa Eldeen Senousy
    Cabrera, Roniel
    CHINESE CLINICAL ONCOLOGY, 2013, 2 (04)
12345